EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Kampo medicine, kamishoyosan, ameliorates menstruation-associated symptoms in patients with premenstrual syndrome: An exploratory open-label, randomized controlled trial

Jun Chikumi, Eri Sato, Ai Ikebuchi, Yohei Tokita iD, Mitsuto Fukushige, Mayu Yamamoto, Hiroshi Sunada, Yusuke Endo, Hisashi Noma, Tasuku Harada, Fuminori Taniguchi iD

PLOS One · 06.11.2026 · 21 (11) · e0362303

DOI: 10.1371/journal.pone.0362303 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 06.11.2026. Verfasst von Jun Chikumi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tottori University Faculty of Medicine, Obstetrics and Gynecology, Tottori, Japan. Hauptthemen laut MEDLINE: Premenstrual Syndrome, Drugs, Chinese Herbal, Medicine, Kampo, Menstruation. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tsumura and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premenstrual syndrome (PMS) is a psychological or physical symptom. We conducted an open-label, randomized, exploratory trial with the aim of evaluating the efficacy and safety of kamishoyosan (KSS) for PMS. KSS was administered orally during three menstrual cycles. The primary endpoint was the change in the premenstrual Menstrual Distress Questionnaire (MDQ) total score. The secondary endpoints included MDQ total and subscale scores, a daily symptom questionnaire, the Work Productivity and Activity Impairment (WPAI) Questionnaire, overall impressions, sleep status, and heart rate. A total of 50 patients were enrolled. The primary endpoint, the premenstrual MDQ total score, was significantly ameliorated after KSS treatment. Furthermore, KSS reduced MDQ scores during the menstrual cycle. Among the MDQ subscales, KSS decreased score of pain, concentration, behavioral change, and negative feelings during the premenstrual cycle. In addition, hyperthymia reduced during the menstrual cycle. The results of the daily symptom questionnaire indicated that KSS treatment alleviated irritability, easy anger, anxiety, emotional instability, abdominal distension, coldness, and stiff shoulders.The WPAI activity impairment score was lower in the KSS group, and overall impression favoured in KSS treatment.. The only adverse event related to KSS was headache in one case. These exploratory findings suggest that KSS may improve menstrual-related symptoms in PMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premenstrual SyndromeDrugs, Chinese HerbalMedicine, KampoMenstruationHumansFemaleAdultSurveys and QuestionnairesYoung AdultTreatment OutcomeMenstrual Cycle

Substanzen

Drugs, Chinese Herbalkamisyoyo san

Autor:innen und Institutionen

  • Tottori University Faculty of Medicine, Obstetrics and Gynecology, Tottori, Japan.
  • Tottori University Faculty of Medicine, Health Service Center, Tottori, Japan.
  • TSUMURA Kampo Research Laboratories, Research & Development Division, TSUMURA & CO., Tokyo, Japan.
  • Advanced Medicine, Innovation and Clinical Research Center, Tottori University Hospital, Tottori, Japan.
  • Organization for Research Institute and Promotion, Tottori University, Tottori, Japan.
  • Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan.

ORCID-Profile: Yohei Tokita, Fuminori Taniguchi

Förderung

  • Tsumura and Company

Zitieren

APA

Chikumi, J., Sato, E., Ikebuchi, A., Tokita, Y., Fukushige, M., Yamamoto, M., Sunada, H., Endo, Y., Noma, H., Harada, T., & Taniguchi, F. (2026). A Kampo medicine, kamishoyosan, ameliorates menstruation-associated symptoms in patients with premenstrual syndrome: An exploratory open-label, randomized controlled trial. PLOS One, 21(11), e0362303. https://doi.org/10.1371/journal.pone.0362303

Vancouver

Chikumi J, Sato E, Ikebuchi A, Tokita Y, Fukushige M, Yamamoto M, et al. A Kampo medicine, kamishoyosan, ameliorates menstruation-associated symptoms in patients with premenstrual syndrome: An exploratory open-label, randomized controlled trial. PLOS One. 2026;21(11):e0362303. doi:10.1371/journal.pone.0362303

BibTeX
@article{Chikumi2026,
  author = {Chikumi, Jun and Sato, Eri and Ikebuchi, Ai and Tokita, Yohei and Fukushige, Mitsuto and Yamamoto, Mayu and Sunada, Hiroshi and Endo, Yusuke and Noma, Hisashi and Harada, Tasuku and Taniguchi, Fuminori},
  title = {A Kampo medicine, kamishoyosan, ameliorates menstruation-associated symptoms in patients with premenstrual syndrome: An exploratory open-label, randomized controlled trial},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0362303},
  doi = {10.1371/journal.pone.0362303}
}
Kostenlos starten →